Home › Study finds that drug labelling change may add $4bn to US health care costs
 

Keywords :   


Study finds that drug labelling change may add $4bn to US health care costs

2014-02-07 01:00:00| Packaging Gateway

The Food and Drug Administration's (FDA) recently proposed regulation affecting generic drug labelling may result in an estimated $4bn in additional US health care costs a year, according to an analysis by economic consulting firm Matrix Global Advis

Tags: add change health care

Category:Industrial Goods and Services

Latest from this category

All news
01.07Mentorship in Motion
Industrial Goods and Services »
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »